Noncoding RNA by Desgranges, E. et al.
HAL Id: hal-02112074
https://hal.archives-ouvertes.fr/hal-02112074
Submitted on 27 Oct 2020
HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.
L’archive ouverte pluridisciplinaire HAL, est
destinée au dépôt et à la diffusion de documents
scientifiques de niveau recherche, publiés ou non,
émanant des établissements d’enseignement et de
recherche français ou étrangers, des laboratoires
publics ou privés.
Noncoding RNA
E. Desgranges, S. Marzi, K. Moreau, P. Romby, Isabelle Caldelari
To cite this version:
E. Desgranges, S. Marzi, K. Moreau, P. Romby, Isabelle Caldelari. Noncoding RNA. Microbiology
Spectrum, American Society for Microbiology, 2019, 7 (2), ￿10.1128/microbiolspec.GPP3-0038-2018￿.
￿hal-02112074￿
Gram-positive pathogens, 3rd Edition (ASM) 
 
Staphylococcus section 
 
Chapter 5: non-coding RNA 
 
Desgranges, E. 1, Marzi, S. 1, Moreau, K. 2, Romby, P1, and Caldelari I1*. 
1Université de Strasbourg, CNRS, Architecture et Réactivité de l’ARN, UPR9002, F-67000 
Strasbourg, France 
2CIRI, International Center for Infectiology Research, Inserm, U1111, Université Claude 
Bernard Lyon 1, CNRS, UMR5308, École Normale Supérieure de Lyon, Hospices Civils de 
Lyon, Univ Lyon, F-69008, Lyon, France 
 
*corresponding author 
  
General introduction  
 Regulatory RNAs have been identified in many bacteria, and in pathogenic bacteria 
such as Staphylococcus aureus, where they play major roles in the regulation of virulence or 
metabolic proteins synthesis, beside transcriptional factors and two component systems 
(Bischoff and Romby, 2016, Tomasini et al., 2014, Guillet et al., 2013, Caldelari et al., 2011). 
Most of them are non-coding RNAs (sRNAs) but some of them express small peptides. 
Certain sRNAs, acting in cis, are situated at the 5'-untranslated regions (UTR) of mRNAs, and 
act as sensors of metabolites, tRNA or environmental stimuli (temperature, pH, …) or at the 
3'-UTR. In contrast, the genes encoding sRNAs, which act in trans, sit on the opposite strand 
of the regulated mRNA or at genomic locations distant from the mRNAs they regulate. Cis-
encoding sRNAs, also called antisense RNAs (asRNA), are fully complementary to their 
targets. In contrast, trans-encoding sRNAs share only partial complementarity, and as a 
consequence, they can regulate many mRNAs. Most of them are encoding mainly on the core 
genome while few of them are localised within mobile elements, pathogenic islands or 
plasmids. In this review, we will focus on the most recent mechanisms of RNA regulation 
discovered in S. aureus and how regulatory RNAs are part of sophisticated networks that 
allow the bacteria to adapt quickly to its environment or survive into its host.  
 
5’-UTR of mRNAs contain riboswitches, T-boxes or thermosensors with potential impact for 
novel antibiotherapy 
 The riboswitches and T-box are found in the 5’-UTR of some mRNAs and contain 
highly structured domains, which recognize metabolites such as cofactors, vitamins, amino-
acids, nucleotides, second messenger cyclic di-GMP, Mg2+ or non aminoacylated tRNAs 
(Quereda and Cossart, 2017). Binding of these metabolites confers structural changes that 
modify the expression of the downstream mRNA, for example by inducing premature 
transcription arrest, repression/activation of translation, or cleavage. T-box senses the 
aminoacylation status of tRNAs and mainly control transcription of downstream genes that 
encode proteins involved in the biosynthesis, transport of amino acids or aminoacylation of 
tRNAs. Based on sequence and structure conservation, most of the T-box and riboswitches 
were predicted in S. aureus genomes (Caldelari et al., 2011). A large part of riboswitches 
control expression of genes involved in metabolic pathways. Because these genes are often 
essential for growth, they thus represent interesting targets for the development of alternative 
antimicrobial drugs in the battle against multi-drugs resistant S. aureus. This strategy was 
used with the guanine and the glucosamine-6-phosphate (GlcN6P) riboswitches. Mulhbacher 
et al. (2010) have identified a pyrimidine derivative that binds to the guanine riboswitch and 
represses the expression of guaA. This compound significantly reduced the infection by S. 
aureus in a mouse model of infection. In Gram-positive bacteria, the glmS mRNA is both a 
ribozyme, which catalyses its own cleavage and a riboswitch responding to GlcN6P. Its 
product encodes an essential enzyme, which converts fructose-6-phosphate into GlcN6P, a 
building block of bacterial peptidoglycan. A tight regulation of glmS mRNA is crucial to 
maintain a homeostatic level of GlcN6P in the cell. At high concentrations of GlcN6P, its 
binding to the 5’-UTR of glmS leads to a site-specific self-cleavage, which generates a 5′-
hydroxylated end molecule rapidly degraded by the RNase J1 (Collins et al., 2007, Lünse et 
al., 2011). A recent study leads to the design, synthesis, and characterization of a GlcN6P 
analogue, carba-GlcN6P, which constitutively activates the glmS ribozyme of vancomycin-
resistant S. aureus and destabilizes its mRNA (Lünse et al., 2011). This compound was 
experimentally shown to induce an efficient self-cleavage of the glmS mRNA similar to the 
natural metabolite and thus represented an important step in the development of antibiotics 
with a new mode of action. Very recently, a new approach called “Term-seq” revealed that 
several antibiotic resistance genes are under the control of riboswitches responding to 
commonly used antibiotics against Gram-positive pathogenic bacteria such as Listeria or 
Enterococcus faecalis (Dar et al., 2016). These results suggest that the same phenomenon 
could exist in S. aureus and that RNA-mediated regulation could play a broader role than 
expected in antibiotic resistance mechanisms.  
Not surprisingly, the presence of antibiotics can also modulate the regulatory activity 
of T-box. In S. aureus, an unusual glyS T-box regulates transcription antitermination of the 
unique glycyl-tRNA synthetase (glyRS) gene responsible to catalyse the aminoacylation of 
the five tRNAGly isoacceptors, independently of their anticodon (GCC or UCC) and with 
different binding affinities (Apostolidi et al., 2015). Thereafter, the T-box senses the 
availability of glycine not only for its incorporation into nascent polypeptide chains during 
translation but also for the formation of pentaglycine bridges into the peptidoglycan molecule, 
linking two essential pathways. Antibiotics targeting the small ribosomal subunit stabilized 
the T-box/tRNA complex and induced a read-through of transcription while chloramphenicol 
and linezolid attenuated glyS transcription (Stamatopoulou et al., 2017). The outcome 
depended on the binding sites of the protein synthesis inhibitors (Stamatopoulou et al., 2017). 
Although T-box and riboswitches can be targets for antibiotics against important human 
pathogens as S. aureus, they also presented unexpected off-target effect.  
  RNA thermosensors are regulatory elements often localised at the 5’-UTR of mRNA 
encoding heat or cold shock proteins and virulence factors (for review Kortmann and 
Narberhaus, 2012). Briefly, at low temperatures, the mRNA cannot be translated since the 
Shine and Dalgarno (SD) sequence is trapped into a hairpin structure, which melts gradually 
when temperature increases. The best-studied example in Gram-positive bacteria is the 
thermosensor regulating the expression of the transcriptional factor prfA, which further 
activates most of the virulence genes in Listeria monocytogenes (Johansson et al., 2002, Loh 
et al., 2012). Such example has not been demonstrated yet in other Gram-positive bacteria 
including S. aureus.  
 
3’-UTRs of mRNAs act in cis or are reservoirs of sRNAs  
 Transcriptome analysis of the human pathogen S. aureus revealed that at least one-
third of mRNAs carry long 3’-UTRs, and thus might display multiple regulatory functions 
(Lasa et al., 2012). Some of them have direct action on the expression of their own mRNA 
(Lasa, et al., 2012, Ruiz de los Mozos et al., 2013). Long 3’-UTRs (>100 nucleotides) can 
end at an intrinsic Rho-independent terminator of transcription (TT), can be generated from a 
specific RNase cleavage, or from a terminating-read-through of the RNA polymerase. 
Remarkably, several 3’-UTRs contained riboswitches as the result of a metabolite-sensing 
regulation (Ruiz de los Mozos et al., 2013). Indeed, the TT of the riboswitch in an OFF 
conformation also serves as the TT of the gene encoded upstream of the riboswitch.  
A singular example of a new post-transcriptional regulatory mechanism was shown for 
the icaR mRNA, which possesses an unusual long 3’-UTR (390 bp). In this case, the 
expression of the mRNA is modulated through a long-distant interaction between 3'-UTR and 
5'-UTR (Ruiz de los Mozos et al., 2013). Because icaR codes for a transcriptional repressor of 
the icaADBC operon encoding enzymes involved in the synthesis of PIA-PNAG, the main 
polysaccharides of the biofilm matrix, the regulation has direct impact on biofilm formation. 
Base-pairing interactions between the long 3’-UTR of icaR mRNA and the SD sequence of 
the same mRNA hindered efficient translation initiation (Ruiz de los Mozos et al., 2013). This 
long range RNA duplex generated a specific site for the double-strand endoribonuclease III 
(RNase III) for cleavage. As a consequence, PIA-PNAG synthesis increased. Yet the 
mechanism allowing IcaR translation is unknown to prevent the action of the 3’-UTR as a cis-
acting antisense RNA (figure 1).  
It is also postulated that 3’-UTR length provides other types of transcript-specific 
regulation. Indeed in Salmonella sp., the 3’-UTRs are also reservoirs for sRNAs, which 
originated either by transcription from an internal promoter or by processing. In both cases, 
the sRNA generated from the 3’-UTR regulated trans-encoded mRNA targets. For instance, 
the sRNA CpxQ is cleaved by RNase E from the 3’-UTR of cpxP and repressed the 
translation of mRNAs encoding a family of envelope proteins while DapZ is transcribed from 
an internal promoter within the dapB gene and inhibited translation of the major ABC 
transporters, DppA and OppA (Chao et al., 2012, Chao and Vogel, 2016, for review see 
Miyakoshi et al., 2015). Recent works showed that such 3’-UTR-derived sRNA also existed 
in S. aureus although their functions remained to be addressed (Desgranges et al., 
unpublished data). 
 
AsRNAs in pervasive transcription and acting as anti-toxins  
  AsRNAs are transcribed from the opposite strand of the mRNAs they regulate, so 
that they display perfect complementarities with their target. Short asRNAs are often encoded 
on mobile elements such as plasmids, transposons, and phage-like elements. Such elements 
can ptentially be transferred horizontally to other bacterial species or be duplicated (Fozo et 
al., 2008). In S. aureus, they were first described to control plasmid conjugation and 
replication (Novick et al., 1989). The size of asRNAs can vary from 10 to thousands of 
nucleotides, because these RNAs can overlap with part of a gene (3’ or 5’ ends), the entire 
gene or a group of genes (figure 1). This phenomenon is called pervasive transcription. 
Initially pervasive transcription was considered as a non-functional transcriptional noise. 
However, considering the large number of asRNAs expressed from the entire genome and in 
several bacterial species, these RNAs might play an important role in the regulation of gene 
expression. Genome-wide analysis of S. aureus highlighted that the expression of a significant 
proportion (75%) of antisense transcripts to annotated open reading frames are synthesized 
from the complementary strand and that these sense/antisense duplexes are digested by 
RNase III generating short fragments all along the genome (Lasa et al., 2011). Another study 
using RIP-Seq approach confirmed the involvement of RNase III in the regulation of 
sense/antisense transcripts and overlapping UTRs (Lioliou et al., 2012). The situation might 
be even more complex as recent results suggested that the termination factor Rho play a major 
role to prevent pervasive transcription in B. subtilis, but also in S. aureus (Bidnenko et al., 
2017, Mäder et al., 2016). Although the biological outcome of pervasive transcription is not 
clearly understood, some of the produced asRNAs are functional and control several 
biological processes (Lasa et al., 2012).  
 Type I toxin-antitoxin (TA) systems are particular cases of short asRNAs, in which 
the antitoxin is an asRNA regulating the translation or the fate of the toxin encoding mRNA, 
whereas in the type III system, the anti-toxin sequesters the toxin (review by Goeders et al., 
2016; Coray et al., 2017). In S. aureus, several type I TA module systems have been 
described (review of Brielle et al., 2016). One of them, called SprF1/SprG1, expresses SprF1 
as the asRNA and sprG1 mRNA, which encodes two short secreted peptides with haemolytic 
and antibacterial activity (Pinel-Marie et al., 2014). The anti-toxin SprF1 binds to the 3’-end 
of sprG1 mRNA that leads to mRNA degradation and inhibition of peptide synthesis to 
protect cells against lethality (Pinel-Marie et al., 2014). The SprA1/asSprA1 pair is another 
intriguing and unconventional system. The asSprA1 is transcribed from the opposite strand of 
the sprA1 mRNA producing a cytolytic peptide. Their 3’ends overlapped by 35 nucleotides 
but experimental data indicated that the functional domain of asSprA1 is outside the 
complementary sequence with sprA1 mRNA. Both RNAs were expressed concomitantly and 
asSprA1 5’ base-paired with the ribosome-binding site (RBS) of sprA1 impairing its 
translation (Sayed et al., 2012). Thus asSprA1 acts as a trans regulator with its 
complementary target, suggesting that it can potentially interact with other RNA targets. 
Finally, a cluster of five genes encoding sRNAs specific to the S. aureus Newman strain 
contained a putative TA system (Bronsard et al., 2017) (figure 1). Three genes were 
transcribed from the positive strand, two from the negative strand. Moreover, one small open 
reading frame was detected within one of the gene from the minus strand and coded for a 
secreted peptide with similarity to the RelE toxin (Neubauer et al., 2009). Whether these two 
overlapping genes corresponded to a novel TA system remained to be addressed. Interestingly 
this locus was expressed in a growth-phase dependent manner, in nutriment starvation and 
oxidative stress. Type I TA systems have been involved in many functions (membrane 
depolarization, plasmid maintenance) mainly in Escherichia coli among which persistence 
(for review Berghoff and Wagner, 2017), but not in S. aureus until now (Brielle et al., 2016).    
   
Transcriptional factors and sRNAs build complex regulatory networks 
 Trans-acting sRNAs regulate mRNAs by imperfect base-pairings, which signifies that 
one sRNA can modulate several targets and one target can be controlled by several sRNAs. In 
S. aureus, the annealing region between sRNA and mRNAs are often longer than in E. coli 
and mostly targets the ribosome binding site (RBS) of mRNAs affecting translation. In 
several cases, a second distinct site of interaction occurs in the coding region. Unlike Gram-
negative bacteria, in which Hfq and ProQ proteins participate to the sRNA regulation by 
stabilizing and facilitating their pairings with mRNA targets (see reviews Updegrove et al., 
2016; Attaiech et al., 2017), no RNA chaperones have been yet identified in S. aureus. 
Indeed, proQ is not encoded and the role of Hfq is still unclear. Recent work has shown that 
the rim domain of Hfq has an amino-acid composition (low in arginine) incompatible with 
RNA annealing activity compared to E. coli Hfq (Zheng et al., 2016). The sRNAs belong to 
intricate networks of regulation and their synthesis is often dependent of transcription factors 
or of two components systems, in addition sRNAs can also control transcription factors at the 
post-transcriptional level (figure 2). Examples will be described below.  
 AgrA, the responsive regulator of the agr quorum sensing system, activates the 
transcription of RNAIII. This bifunctional RNAIII codes for δ-hemolysin and regulates the 
expression of virulence genes at the post-transcriptional level (see below). It interacts with 
various mRNAs either to activate or to repress translation. The RBS of hla mRNA encoding 
α-hemolysin is embedded into a hairpin, which prevents the ribosome to bind and start 
translation. The 5’-UTR of RNAIII possesses complementary sequences to the leader region 
of hla. Interactions between both RNAs would recruit ribosomes to initiate Hla translation. In 
its 3’-UTR, RNAIII carries conserved UCCC motifs that are used as the seed sequences to 
bind with the RBS of the target mRNAs coding for the Protein A, the coagulase, the Sbi 
protein, the transcription factor Rot, the repressor of exotoxins, and the endopeptidase LytM 
(for review, Bronesky et al., 2016). Moreover, AgrA repressed the sRNA ArtR, which 
inhibits translation of the SarA homolog SarT (Xue et al., 2014) and activated RsaE (see 
below, Geissmann et al., 2009) (figure 2). 
 The staphylococcal accessory regulator SarA is synthesised from three distinct 
promoters (P1, P2, P3) and binds DNA or RNA (Bischoff and Romby, 2016). As a 
transcription factor, it regulates many genes involved in virulence, autolysis, biofilm 
formation, stress response, antibiotic resistance, or metabolism, but also two sRNAs, SprC 
and Srn_9340 located on the same pathogenicity island (Mauro et al., 2016). SprC prevented 
ribosomes to bind the SD of the atl mRNA coding for an autolysin, then reducing 
internalization by macrophages and attenuating virulence (Le Pabic et al., 2015). SarA 
repressed both sprC and srn_9340 transcription and required an ATTTTAT sequence in its 
binding site (Mauro et al., 2016). However, while SarA level remains relatively constant 
along the bacterial growth, the expression of SprC fluctuated, which suggest that additional 
factors might control its synthesis and that a mechanism of derepression should co-exist under 
specific conditions. These are very first examples of two sRNAs regulated by the same 
transcription factor.  
In the following, we will describe an sRNA, whose transcription is controlled by three 
independent transcription factors. The sRNA RsaE possesses two consensus sequence motifs 
UCCC as found in RNAIII, which interact with the RBS of several mRNAs involved in 
central metabolism to repress their translation (Geissmann et al., 2009, Bohn et al., 2010).  
RsaE is highly conserved between Staphylococcaceae and Bacillaceae families. Not only the 
sequence of RsaE is conserved between B. subtilis and S. aureus species, but also its 
regulation and functions. Recent studies have shown that its transcription is activated by the 
two component systems SrrAB (staphylococcal respiratory response) in response to NO and a 
binding site for the redox sensing repressor Rex has been predicted (Geissmann et al., 2009, 
Durand et al., 2015, 2017). In B. subtilis, the Rex-repression of RsaE (also called RoxS) has 
been proposed to readjust the cellular balance of NAD+/NADH upon various signals (Durand 
et al., 2017). 
 The alternative sigma B factor (sB) together with the RNA polymerase guides 
transcription of genes mainly in the stationary phase of growth and under stress conditions. Its 
regulon comprises more than 200 genes including several virulence factors, transcription 
factors and sRNAs (figure 2, Bischoff et al., 2004). Among the sRNAs induced by sB are 
SbrA, B, C activated by KOH (Nielsen et al., 2011) and RsaA (Geissman et al., 2009). The 
stability of RsaA depended on RNase III and the endoribonuclease RNase Y, which is part of 
the degradosome in S. aureus (Lioliou et al., 2012, Marincola et al., 2012, Roux et al., 2011). 
RsaA acts as an acute virulence attenuator in S. aureus (see below) by inhibiting translation of 
the MgrA transcription factor (figure 2, Romilly et al., 2014) and indirectly by activating the 
synthesis of several surface proteins (Tomasini et al., 2017). RsaA possesses two UCCC 
motifs, which in the case of mgrA mRNA bind to two distant regions, involving an imperfect 
duplex masking the SD sequence of the mRNA and a loop-loop interaction occurring 
downstream in the coding region. These two distant binding sites are required for efficient 
repression and RNase III-dependent degradation of the repressed mRNA (Romilly et al., 
2014). Finally, the sRNA Teg49 is generated from the sB- dependent P3 promoter of sarA and 
is most probably processed by RNase III and RNase Y with the help of the helicase CshA 
(Beaume et al., 2010, Kim et al., 2014, Manna et al., 2017). Transcriptomic analyses revealed 
that beside genes involved in virulence and autolysis, Teg49 might post-transcriptionally 
affected the SaeRS and LytRS two-component systems, yet the exact mechanism is not 
known (Manna et al., 2017). On top of that, another sRNA Teg48, whose role is not known, 
was processed from the P1 promoter of sarA (figure 2). Even if the maturation process and 
the function of Teg48 and Teg49 are not clearly established, it describes a putative novel 
reservoir of sRNA from long 5’-UTR of a mRNA encoding a master regulator of virulence in 
S. aureus. 
 
crRNA, tracrRNA and the CRISPR Cas adaptive immunity systems in S. aureus 
 Phages are the most abundant forms of life on earth and the natural killers of bacteria 
as in most cases their lytic life cycle ends with the death of the bacterial cell. Outnumbering 
their microbial hosts, phages impose a selective pressure to the diversification of microbial 
defense systems (Breitbart and Rohwer, 2005). These include various innate phage-resistance 
mechanisms such as restriction/modification enzymes, receptor masking, blocking DNA 
injection, abortive infection (Labrie et al., 2010; Westra et al., 2012), and the adaptive 
defense mechanism based on clustered, regularly interspaced short palindromic repeat 
(CRISPR) and CRISPR-associated (cas) genes (Barrangou et al., 2007; Makarova et al., 
2006). The latter RNA-interference-like mechanism relies on small non coding RNAs, crRNA 
and in some cases tracrRNA, through which prokaryotic hosts (bacteria and archaea) can 
acquire heritable resistance to genetic parasites like phages, but also plasmids and transposons 
(for reviews see (Westra et al., 2012; Wiedenheft et al., 2012)). To date, CRISPR-Cas 
systems have been found in about 50% of bacterial genomes and 95% of archaeal genomes 
(Grissa et al., 2007; Makarova et al., 2015). The CRISPR and the cas locus are often located 
next to each other in the genomes, sometimes organized into operons, but a significant 
number of genomes have also isolated cas loci and/or CRISPRs (Haft et al., 2005).  
 Despite a large diversity of the CRISPR-cas systems, they share common features. 
Briefly, the CRISPR loci are characterized by an array of short and palindromic repetitive 
sequences interspaced by sequences called “spacers” that are coming from plasmid and 
viruses. These spacers are first integrated into the host genome to provide immunity to the 
host (acquisition step, i.e., (Horvath and Barrangou, 2010; Nunez et al., 2014)) and during a 
second event of infection they are transcribed and used as guides to inactivate the viral 
genome. This two-step pathway involves a variety of Cas proteins, leading to several major 
types of CRISPR-cas systems (reviewed in (Makarova et al., 2015; Marraffini, 2015)). 
However, the acquisition step involves two highly conserved Cas1 and Cas2 proteins 
(Makarova et al., 2015; Yosef et al., 2012). The Cas1-Cas2 integrase is a heterohexameric 
complex of four Cas1 and two Cas2 which preferentially incorporates foreign DNA at the first 
CRISPR repeat, participates in the discrimination against self-DNA and in the minimization 
of off-targeting insertions (Levy et al., 2015; Modell et al., 2017; Wright et al., 2017). Both 
proteins have been found in several S. aureus strains (Grissa et al., 2007). During the second 
step, activation of transcription from a promoter located in an AT-rich leader sequence 
preceding the first CRISPR repeat (Jansen et al., 2002; Pougach et al., 2010) leads to 
expression of the whole array into precursor CRISPR transcripts (pre-crRNA). The pre-
crRNAs are then processed into mature crRNAs consisting of partial repeat(s) and a single 
spacer sequence, each complementary to a unique invader sequence (Haurwitz et al., 2010). 
Different endonucleases participate into the maturation step, which might vary in different 
bacteria. Type I and III system performs the function by a multisubunit Cas protein complex 
and are characterized by Cas6 processing (Haurwitz et al., 2010). Type II uses another sRNA, 
tracrRNA, to direct RNase III-dependent maturation of the pre-crRNA in the presence of 
Cas9, the hallmark protein of the type II system (Deltcheva et al., 2011). Cas9 endonuclease 
remains associated to the dual-tracrRNA:crRNA structure which, during the interference 
phase, guides the cleavage of site-specific cognate target DNA (Jinek et al., 2012). Type I and 
II CRISPR-Cas systems target DNA (Brouns et al., 2008; Zhang and Ye, 2017), whereas type 
III systems provide immunity against DNA and RNA (Strutt et al., 2018). 
 With the completion of genome sequences of several S. aureus strains, it is now clear 
that CRISPR-Cas system is not prevalent and only few strains have been reported to harbor 
this system. Indeed, a CRISPR Finder analysis (Grissa et al., 2007) of the 115 sequenced S. 
aureus genomes present on the CRISPRdb (http://crispr.i2bc.paris-saclay.fr) showed that the 
majority of CRISPR-like loci contain only few spacers (1 or 2), a few have between 3 and 10 
spacers, while only one genome (from methicillin resistant S. aureus 08BA02176, isolated 
from a patient) has 15 spacers. The last example has been analyzed using CRISPRone 
(http://omics.informatics.indiana.edu/CRISPRone) (Zhang and Ye, 2017) showing the 
presence of elements belonging to the Type III-A CRISPR system (including Csm2, Cas1, 
Cas2 and Cas6; Figure 3A). Other isolates share similar organization of the CRISPR-Cas 
systems (MSHR1132, JS395, CIG290 and 21252) and more than 30 CRISPRs are predicted 
to be present in the available S. aureus genomes (draft or complete) (Holt et al., 2011; Zhang 
and Ye, 2017). Nevertheless, multi-locus sequencing typing (MLST) performed on one of 
these isolate (MSHR1132) has shown that it belongs to a divergent clonal complex which 
lacks the genes for production of staphyloxanthin, and which appears to be closely related to 
S. epidermidis and S. lugdunensis (Holt et al., 2011). It has been thus hypothesized that 
CRISPR/cas was present in a common ancestor of S. epidermidis, S. lugdunensis, and S. 
aureus and was later lost in most conventional S. aureus strains. Noteworthy, numerous 
repeat-spacer-like structures resemble CRISPR elements but lack spacer diversity, and have 
been classified as false-CRISPR (Zhang and Ye, 2017). Staphylococcus aureus repeat 
(STAR)-like elements (GC-rich direct repeats) also belong to this class of RNAs for which 
the functions remained to be addressed (Cramton et al., 2000; Purves et al., 2012). More 
recently, a type II-C CRISPR-Cas system was found in a methicillin-resistant S. aureus strain 
isolated from an Irish patient (Figure 3B). This CRISPR element is located on a pseudo SCC-
mec composite island, which has been most probably horizontally acquired from S. 
epidermidis strain (Kinnevey et al., 2013). The peculiarity of this system is that it contains a 
shorter version of Cas9 protein. The crystal structure of a complex containing SaCas9, the 
sgRNA (an artificial fusion product of a crRNA and a tracrRNA (Jinek et al., 2012)) and its 
target DNA provided a model to understand how crRNA and tracrRNA guide Cas9 on the 
target DNA and prepare it for double stranded DNA cleavages (Nishimasu et al., 2015). In 
this structure, the DNA duplex of the protospacer adjacent region (PAM) contains the signals 
recognized by the Cas9 PAM-interacting (PI) domain, which discriminates the invader DNA 
against self-DNA and facilitates the target DNA unwinding leading to the formation of 
heteroduplex. The beginning of the RNA–DNA heteroduplex (“seed” region) adopts a 
distorted structure critical for Cas9-catalyzed DNA cleavage. This conformation resulted from 
the RNA-DNA helix structure, the interactions with protein residues and the RNA helix 
formed by the repeat/anti-repeat regions mimicking the tracrRNA-crRNA interactions (Figure 
3C). The discovery of the smaller Cas9 protein led to recent improvements in genome editing 
(Ran et al., 2015). The seminal works of Jennifer Doudna and Emmanuelle Charpentier on the 
use of CRISPR-Cas systems for genome editing have inspired many studies showing the 
incredible potency of the system (Cong et al., 2013; Jinek et al., 2013; Mali et al., 2013). 
Using Cas9 from Streptococcus pyogenes (SpCas9) (Sakuma et al., 2014) directed by the 
sequence of a single-guide RNA (sgRNA), thousands of publications have reported its 
application for site-specific genome modifications, gene knockouts or replacements, gene 
expression control and functional genome screenings in over 40 different species. 
Interestingly, SaCas9 has been successfully used for eukaryotic genome editing since its 
smaller size makes it easier to be delivered via adeno-associated virus vectors to somatic 
tissues (Ran et al., 2015).  
 The fact that CRISPR-Cas has been mapped on mobile elements in S. aureus MRSA 
confirms the importance of horizontal genes transfer from other co-colinizing bacteria in the 
acquisition of novel functions and in the evolution of S. aureus strains. It remains to be 
analyzed what could be their advantages and why these CRISPR elements are rare in S. 
aureus. Interestingly, transcription of the CRISPR-Cas genes can be highly regulated and 
induced upon infection (Agari et al., 2010; Quax et al., 2013; Young et al., 2012) by 
membrane stress (Perez-Rodriguez et al., 2011) and, in Gram-negative bacteria, by quorum 
sensing (QS) signaling (Hoyland-Kroghsbo et al., 2017; Patterson et al., 2016). Recent work 
has developed genetic engineering tools in order to apply CRISPR/Cas9 system as an 
antimicrobial strategy against S. aureus (Park et al., 2017). Clearly, the CRISPR/Cas9 system 
offers an alternative therapeutic to the conventional antibiotics.  
 
Role of sRNAs in physiopathology 
 The pathogenesis related to S. aureus can take different forms depending on the 
infected tissue and the invading bacterial strain. This is often accompanied by the expression 
of various virulence factors involved in the colonization and the alteration of the tissue but 
also by the capacity to escape from the host immune response. Among key regulators of 
virulence, several sRNAs have been shown to modulate the synthesis of virulence factors in a 
dynamic manner, and some of them contribute to specific aspects of bacterial virulence in 
animal models of infection (Bischoff and Romby, 2016).  
 The most studied RNA in S. aureus is one of the main intracellular effectors of the 
quorum sensing system agr. As described above, RNAIII regulates expression of virulence 
factors known to be associated with infectious diseases. For instance, it represses the 
synthesis of protein A, which triggers inflammatory signalling pathways and contributes to 
evasion of the immune response. Conversely, RNAIII induces the synthesis of a battery of 
toxins, which contribute to the degradation of tissues and subversion of host defenses, such as 
the pore-forming toxins, and peptides with proinflammatory and lytic activities. A recent 
modelisation of the quorum sensing system and of its regulators has illustrated the importance 
of the agr system in promoting dissemination of the bacteria from biofilms or dense 
population (Audretsch et al., 2013; Nitzan et al., 2015). Nevertheless, despite the fact that 
many clinical isolates from acute infections express RNAIII, its steady state level varies 
considerably among them (Jelsbak et al., 2010; Song et al., 2012). In particular, higher level 
of RNAIII has been observed in the increased virulence community acquired MRSA strains 
as compared to other S. aureus lineages (Montgomery et al., 2010; 2008). Interestingly, a 
recent study showed that the level of RNAIII is lower in strains isolated from patients with 
sepsis than those from commensal carrier patients (Bordeau et al., 2016). Perhaps more 
surprisingly, heterogeneity has been reported in patients where agr-positive and agr-negative 
strains co-existed. This has been proposed as one of the criteria, which might modulate the 
outcome of the infections (Painter et al., 2014; Pollitt et al., 2014).  
 S. aureus is also frequently exposed to other microbes during colonization and 
infection, providing opportunities to acquire mobile genetic elements that contribute to the 
evolution of the genome. Some of these genomic islands play key roles in pathogenesis 
through the complementation of new virulence factors (pathogenicity islands) or through the 
synthesis of novel regulators modulating the expression of genes of the core genome. As an 
example, SprD is an important small regulatory sRNA (142-nts long nucleotides) expressed 
from a pathogenic island, which promoted significantly S. aureus diseases in a mouse sepsis 
model of infection (Chabelskaya et al., 2010; Pichon and Felden, 2005). SprD interacted 
through base-pairings with the sbi mRNA, which encodes an immune evasion molecule 
protecting the bacteria against the host immune responses (Haupt et al., 2008; Zhang et al., 
1998). However, the phenotype of the ∆sprD mutant strain was not linked to the SprD-
dependent regulation of sbi since the ∆sbi mutant strain behaved as the wild type strain in the 
mouse sepsis model (Chabelskaya et al., 2010). Therefore, these data strongly suggested that 
SprD might regulate the expression of other proteins important for infection. 
 SSR42 (for small stable RNAs) is a 891-nts long sRNA whose stability is greatly 
enhanced under stationary phase of growth (Anderson et al., 2006; Morrison et al., 2012). It 
regulated the expression of approximately 80 mRNAs in two genetically different S. aureus 
strain backgrounds. While it increased the expression of capsule Cap5a, SSR42 down-
regulated the expression of protein A, α and γ hemolysin, and Panton Valentin Leukocidin 
(PVL) (Morrison et al., 2012). Because no direct binding was evidenced between SSR42 and 
mRNAs encoding virulence determinants, the effect was predicted to be indirect through the 
modulation of the expression of a transcriptional regulator. Phenotypically, the deletion of 
SSR42 gene affected erythrocyte lysis, resistance to opsonisation killing, and pathogenesis in 
a murine model of skin and soft tissue infections (Morrison et al., 2012). More recently, 
SSR42 was selected as an important gene for the intracellular virulence after screening of a 
transposon mutant library pool. After internalization in epithelial cells, the ∆SSR42 mutant 
strain was significantly enriched in the intracellular fraction most likely due to an attenuated 
cytotoxicity (Das et al., 2016) . 
 In contrast to RNAIII, SprD and SSR42, which contributed to enhance virulence of S. 
aureus, other regulatory RNAs behave as attenuators of virulence. This is for instance the 
case of another encoded pathogenicity island sRNA, the so-called SprC (Pichon & Felden, 
2005). Indeed, the virulence of the isogenic strain lacking SprC was significantly and 
reproducibly improved in a mouse systemic model. Futhermore, SprC reduces S. aureus 
phagocytosis by human monocytes and macrophages, and resistance to oxidative stress. This 
phenotype appears to be due, at least in part to the formation of base pairings between SprC 
and atl mRNA which encodes the staphylococcal autolysin (ATL) (Le Pabic et al., 2015). 
Another example is the Psm-mec RNA, which is a bifunctional RNA located into the 
SCCmec mobile genetic element. It encodes a phenol-soluble modulin (PSMmec) cytolytic 
toxin and acted as a translational repressor through direct binding with agrA mRNA (Kaito et 
al., 2013). AgrA activated the transcription of all psm genes such as the PSMα. Therefore, the 
deletion of the psm-mec RNA increased the expression of AgrA which resulted in an increase 
of toxin and PSMα production and enhanced virulence in mice (Kaito et al., 2013). 
Interestingly, community acquired methicillin resistant S. aureus (CA-MRSA) that do not 
carry the psm-mec gene has been shown to be more virulent than the hospital associated 
MRSA that harbors the gene (Kaito et al., 2013; 2011). Finally, a mutant strain that did not 
express the non coding RNA RsaA attenuated the severity of acute systemic infection in a 
mouse model (Romilly et al., 2014). This deletion is linked to the deregulation of MgrA, a 
master regulator of capsule synthesis and clumping (Crosby et al., 2016). This phenotype in 
pathogenesis is most probably linked to the high sensitivity of the mutant strain to 
opsonophagocytosis by host PMNs. Because the expression of these three sRNAs is 
detrimental for bacterial spreading into colonized organisms, one may suggest that during 
evolution they have favour commensalism with the host.  
 In order to evaluate the impact of the sRNA expression in the context of the host 
infection, two studies have explored the possible relationships between infection severity and 
RNA expression levels. In the first study, the expression levels of five sRNAs (RNAIII, 
RsaA, RsaE, RsaG and RsaH) were analyzed in samples from acute cutaneous infection, 
cystic fibrosis sputum or nasal colonization. The expression profiles did not correlate with the 
type of infection but the authors have noticed that the expression of these five RNAs were 
more homogenous in the nasal colonization isolates than in those responsible for infection 
(Song et al., 2012). More recently, the expression levels of RNAIII and SprD were measured 
in 40 strains cultivated from patients with sepsis or septic shock and compared to 21 strains 
isolated from asymptomatic colonized carriers. It appeared that strains from septic shock had 
significantly lower levels of RNAIII and to a lesser extent for SprD (Bordeau et al., 2016). It 
is important to note that this analysis was performed on clinical isolates cultured in vitro and 
does not necessarily reflect the expression of these RNAs during infection within the host. In 
fact, studies to assess the role and importance of RNAs in the establishment or evolution of 
infection are difficult to achieve. The great variability of S. aureus strains, the difficulty to 
obtain highly controlled cohorts of patients, the reliability of sampling protocols, sample 
processing and RNA expression analysis are all obstacles to overcome. Moreover, biological 
variables may influence the analysis since the relationships between host immune system and 
microbe seems to be particularly individualized and can influence the disease outcome 
(Krismer et al., 2017; Brown et al., 2014). Furthermore, interspecies interactions between 
bacterial pathogens and the commensal microbiota, as well as limited nutrients play major 
roles in promoting or in preventing S. aureus colonization (Krismer et al., 2017). 
Interestingly, it was shown that the agr system is repressed by high concentrations of 
haemoglobin in the nasal fluids leading to the expression of several cell surface proteins and 
favouring nasal colonization (Pynnonen et al., 2011). Similar data were observed when S. 
aureus was co-cultivated with the nasal strain of Corynebacterium striatum (Ramsey et al., 
2016). A recent study also demonstrated that the commensal S. epidermidis can influence the 
expression of one ncRNA of S. aureus (Hermansen et al., 2018).  
 Clearly, we are just at the beginning to better appreciate the roles of regulatory sRNAs 
during colonization and in the pathophysiology of S. aureus infections.  
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Figures legends 
 
Figure 1: Several mechanisms of RNA regulation in Staphylococcus aureus. A. Schematic 
drawing of the flavin mononucleotide (FMN) riboswitch. The 5' UTR adopts a particular 
structure recognized by FMN which in turn leads to the stabilization of a stem-loop structure 
sequestrating the Shine and Dalgarno sequence (SD) to inhibit translation. 30S is for the small 
ribosomal subunit. B. The 3’-UTR of the biofilm repressor IcaR possesses a cytosine-rich 
motif, which binds to the Shine-Dalgarno (SD) and hinders ribosomes from its binding site on 
the mRNA  (see text for details). C. Overlapping 5’-UTRs of tagG and tagH mRNAs are 
processed by the endoribonuclease III (Rnase III). Shorter 5’ends might facilitate ribosome 
recruitment. D. The anti-toxin RNA SprF1 interacted at the 3’end of the toxin encoding by 
sprG1 and triggered its degradation. E. A cluster of five sRNAs was sequenced in the S. 
aureus Newman strain that encodes a putative toxin-antitoxin system (see text for details). F 
and G. sRNAs act by an antisense mechanism. Binding of the 5’-UTR of RNAIII to the 5’-
UTR of hla mRNA liberated its SD and activated translation (F) whereas the 3’ domain of 
RNAIII acted as a repressor domain, which contains C-rich motifs for base-pairing with the 
SD of mRNA as coa mRNA depicted in the figure (G). Green bars represent SD sequence, 
black circles are for RNase III (for references and more details, see text). 
 
Figure 2: Examples of complex network between sRNAs and transcriptional factors in 
Staphylococcus aureus in response to stress. Arrows are for activation, bars for repression. In 
blue, are the transcriptional regulators, in green the two-component systems and in red the 
regulatory sRNAs. Red lines corresponded to post-transcriptional regulation and black lines to 
transcriptional regulation. Dotted lines are for the target mRNAs that were not experimentally 
validated. For clarity, only sRNA-dependent mRNA targets encoding transcriptional factors 
were depicted in the figure.  
 
Figure 3. A. Genomic organization of the loci for the Type III-A CRISPR system of the 
Staphylococcus aureus 08BA02176 strain. Type III is the typical S. aureus CRISPR 
organization. The scheme has been obtained using CRISPRone (Zhang and Ye, 2017) and the 
GenBank deposited 08BA02176 genome sequence (RefSeq accession number 
GCF_000296595.1). B. Genomic organization of the loci for the Type II-C CRISPR system 
of the Staphylococcus aureus M06/0171 strain. The CRISPR-Cas genes have been found on a 
staphylococcal cassette chromosome mec (SCCmec) inserted into the 3′ end of the 
chromosomally located orfX gene. The scheme has been obtained using CRISPRone (Zhang 
and Ye, 2017) and the GenBank deposited SCCmec sequence (GenBank accession number 
HE980450.1). C. Cartoon (RNA and DNA) and surface (Cas9) representations of the 
SaCas9–sgRNA–target DNA complex (pdb file 5AXW (Nishimasu et al., 2015)). The SaCas9 
sgRNA consists of the crRNA guide region (crGUIDE represented in pale yellow color) 
forming a heteroduplex with the target DNA strand (tDNA in magenta) and the repeat/anti-
repeat helix (in blue the repeat crRNA derived strand, in green the anti-repeat trascrRNA 
derived strand). The PAM containing DNA duplex is red. Cas9 domains are colored as 
follow: WED domain is cyan, REC domain is pale orange, NUC domain is grey. Molecular 
graphics images have been prepared using PyMol (Schrodinger, 2015). 
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